These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 8792754)
1. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Lydiard RB; Stahl SM; Hertzman M; Harrison WM J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414 [TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788 [TBL] [Abstract][Full Text] [Related]
4. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression. Ravindran AV; Guelfi JD; Lane RM; Cassano GB J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734 [TBL] [Abstract][Full Text] [Related]
5. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861 [TBL] [Abstract][Full Text] [Related]
7. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. Russell JM; Kornstein SG; Shea MT; McCullough JP; Harrison WM; Hirschfeld RM; Keller MB J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659 [TBL] [Abstract][Full Text] [Related]
8. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. Rush AJ; Koran LM; Keller MB; Markowitz JC; Harrison WM; Miceli RJ; Fawcett JA; Gelenberg AJ; Hirschfeld RM; Klein DN; Kocsis JH; McCullough JP; Schatzberg AF; Thase ME J Clin Psychiatry; 1998 Nov; 59(11):589-97. PubMed ID: 9862605 [TBL] [Abstract][Full Text] [Related]
9. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. Bennie EH; Mullin JM; Martindale JJ J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364 [TBL] [Abstract][Full Text] [Related]
10. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder. Lepola U; Arató M; Zhu Y; Austin C J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079 [TBL] [Abstract][Full Text] [Related]
11. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758 [TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Hellerstein DJ; Kocsis JH; Chapman D; Stewart JW; Harrison W Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860 [TBL] [Abstract][Full Text] [Related]
14. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. Hirschfeld RM; Russell JM; Delgado PL; Fawcett J; Friedman RA; Harrison WM; Koran LM; Miller IW; Thase ME; Howland RH; Connolly MA; Miceli RJ J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378 [TBL] [Abstract][Full Text] [Related]
17. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277 [TBL] [Abstract][Full Text] [Related]
19. Sertraline and imipramine for the treatment of dysthymia. de Jonghe F Arch Gen Psychiatry; 1997 Oct; 54(10):973. PubMed ID: 9337782 [No Abstract] [Full Text] [Related]
20. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group. Mehtonen OP; Søgaard J; Roponen P; Behnke K J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]